Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)-induced pneumonia
作者： Ashok K Shetty , None
关键词:
摘要: A new study published by the journal Aging & Disease reported that intravenous administration of clinical-grade human mesenchymal stem cells (MSCs) into patients with coronavirus disease 2019 (COVID-19) resulted in improved functional outcomes (Leng et al., Dis, 11:216-228, 2020). This demonstrated infusion MSCs is a safe and effective approach for treating COVID-19 pneumonia, including elderly displaying severe pneumonia. acute respiratory illness caused named syndrome 2 (SARS-CoV-2). Currently, patients, particularly those afflicted challenging as no specific drugs or vaccines against SARS-CoV-2 are available. Therefore, MSC therapy inhibiting overactivation immune system promoting endogenous repair improving lung microenvironment after infection found this striking. Additional studies larger cohort needed to validate therapeutic intervention further, however.
aginganddisease.org参考文章(21)
Darwin J Prockop, Joo Youn Oh, Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation Molecular Therapy. ,vol. 20, pp. 14- 20 ,(2012) , 10.1038/MT.2011.211
Ryang Hwa Lee, Andrey A. Pulin, Min Jeong Seo, Daniel J. Kota, Joni Ylostalo, Benjamin L. Larson, Laura Semprun-Prieto, Patrice Delafontaine, Darwin J. Prockop, Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6 Cell Stem Cell. ,vol. 5, pp. 54- 63 ,(2009) , 10.1016/J.STEM.2009.05.003
Richard J. Hodes, Aging and the immune system Immunological Reviews. ,vol. 160, pp. 5- 8 ,(1997) , 10.1111/J.1600-065X.1997.TB01022.X
Jennifer G Wilson, Kathleen D Liu, Hanjing Zhuo, Lizette Caballero, Melanie McMillan, Xiaohui Fang, Katherine Cosgrove, Rosemary Vojnik, Carolyn S Calfee, Jae-Woo Lee, Angela J Rogers, Joseph Levitt, Jeanine Wiener-Kronish, Ednan K Bajwa, Andrew Leavitt, David McKenna, B Taylor Thompson, Michael A Matthay, Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial The Lancet Respiratory Medicine. ,vol. 3, pp. 24- 32 ,(2015) , 10.1016/S2213-2600(14)70291-7
Peter Connick, Madhan Kolappan, Charles Crawley, Daniel J Webber, Rickie Patani, Andrew W Michell, Ming-Qing Du, Shi-Lu Luan, Daniel R Altmann, Alan J Thompson, Alastair Compston, Michael A Scott, David H Miller, Siddharthan Chandran, Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study Lancet Neurology. ,vol. 11, pp. 150- 156 ,(2012) , 10.1016/S1474-4422(11)70305-2
I Hamming, W Timens, MLC Bulthuis, AT Lely, GJ Navis, H van Goor, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis The Journal of Pathology. ,vol. 203, pp. 631- 637 ,(2004) , 10.1002/PATH.1570
Shahrukh Hashmi, Mohammad Ahmed, M Hassan Murad, Mark R Litzow, Roberta H Adams, Lynne M Ball, Vinod K Prasad, Partow Kebriaei, Olle Ringden, None, Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis The Lancet Haematology. ,vol. 3, ,(2016) , 10.1016/S2352-3026(15)00224-0
Darwin J. Prockop, The exciting prospects of new therapies with mesenchymal stromal cells Cytotherapy. ,vol. 19, pp. 1- 8 ,(2017) , 10.1016/J.JCYT.2016.09.008
Diane L Kamen, Paul J Nietert, Hongjun Wang, Tara Duke, Colleen Cloud, Angela Robinson, Gary S Gilkeson, CT-04 Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) in patients with systemic lupus erythematosus: results of an open-label phase I study Lupus science & medicine. ,vol. 5, ,(2018) , 10.1136/LUPUS-2018-LSM.76
Ashok K Shetty, Maheedhar Kodali, Raghavendra Upadhya, Leelavathi N Madhu, None, Emerging Anti-Aging Strategies - Scientific Basis and Efficacy. Aging and Disease. ,vol. 9, pp. 1165- 1184 ,(2018) , 10.14336/AD.2018.1026